ArticleJournal of synchrotron radiation2019
Coherent Bragg imaging of 60 nm Au nanoparticles under electrochemical control at the NanoMAX beamline.
Article in Journal of synchrotron radiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Machine learning assisted masking of parasitic signals in Bragg coherent diffraction imaging.Journal of synchrotron radiation · 2026Article
- Correcting angular distortions in Bragg coherent X-ray diffraction imaging.Journal of synchrotron radiation · 2024Article
- Bragg coherent diffraction imaging of single 20 nm Pt particles at the ID01-EBS beamline of ESRF.Journal of applied crystallography · 2022Article
- Design and performance of a dedicated coherent X-ray scanning diffraction instrument at beamline NanoMAX of MAX IV.Journal of synchrotron radiation · 2022Article
- X-ray in-line holography and holotomography at the NanoMAX beamline.Journal of synchrotron radiation · 2022Article
- NanoMAX: the hard X-ray nanoprobe beamline at the MAX IV Laboratory.Journal of synchrotron radiation · 2021Article
- Bragg Coherent Diffraction Imaging forACS nano · 2021Article
- On Compton scattering as a source of background in coherent diffraction imaging experiments.Journal of synchrotron radiation · 2021Article
- Combining Laue diffraction with Bragg coherent diffraction imaging at 34-ID-C.Journal of synchrotron radiation · 2020Article
- Continuous scanning for Bragg coherent X-ray imaging.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nanoparticles are essential electrocatalysts in chemical production, water treatment and energy conversion, but engineering efficient and specific catalysts requires understanding complex structure-reactivity relations. Recent experiments have shown that Bragg coherent diffraction imaging might be a powerful tool in this regard. The technique provides three-dimensional lattice strain fields from which surface reactivity maps can be inferred. However, all experiments published so far have investigated particles an order of magnitude larger than those used in practical applications. Studying smaller particles quickly becomes demanding as the diffracted intensity falls. Here, in situ nanodiffraction data from 60 nm Au nanoparticles under electrochemical control collected at the hard X-ray nanoprobe beamline of MAX IV, NanoMAX, are presented. Two-dimensional image reconstructions of these particles are produced, and it is estimated that NanoMAX, which is now open for general users, has the requisites for three-dimensional imaging of particles of a size relevant for catalytic applications. This represents the first demonstration of coherent X-ray diffraction experiments performed at a diffraction-limited storage ring, and illustrates the importance of these new sources for experiments where coherence properties become crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.